{"schema_version":"1","generated_at":"2026-11-20T12:25:35.271Z","data_as_of":null,"url":"https://www.findmykol.com/kol/shagufta-shaheen","json_url":"https://www.findmykol.com/kol/shagufta-shaheen/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"shagufta-shaheen","name":"Shagufta Shaheen","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Stanford Medicine","institution_url":"https://www.findmykol.com/institution/stanford-university-school-of-medicine","city":"Stanford","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"on_file":["npi","orcid","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Shagufta Shaheen is an Oncology physician affiliated with Stanford Medicine. OpenAlex indexes 64 publications with 1,115 citations (h-index 9); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":64,"cited_by_count":1115,"h_index":9,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01525082","title":"Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Shaheen Shagufta","source_url":"https://clinicaltrials.gov/study/NCT01525082","trial_url":"https://www.findmykol.com/trial/NCT01525082"}],"source":"trials"},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":9,"shown":3,"withheld":6,"rows":[{"payer":"Boehringer Ingelheim Pharmaceuticals, Inc.","program_year":2025,"amount_usd":3552.5,"payment_count":1},{"payer":"Eli Lilly and Company","program_year":2025,"amount_usd":3176.34,"payment_count":5},{"payer":"Exelixis Inc.","program_year":2025,"amount_usd":2599.83,"payment_count":4}],"source":"payments"},"prescribing":{"data_year":2022,"areas_total":1,"areas_shown":1,"areas":[{"area":"Blood & clotting","share_pct":100,"classes_total":1,"classes":[{"class":"Salt solutions","setting":"prescribed","share_pct":100,"drugs":[{"name":"Sodium Chloride","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2022,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Evolving Therapeutic Strategies in Neuroendocrine Neoplasms: A New Era of Personalized Therapies","year":2026,"journal":"American Society of Clinical Oncology Educational Book","source_url":"https://doi.org/10.1200/edbk-26-518934","status":"verified"},{"title":"Once-daily oral paltusotine in the treatment of patients with carcinoid syndrome: Biomarker analysis results from a phase 2, randomized, parallel-group study.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.2_suppl.632","status":"verified"},{"title":"Clinical benefit of various HER2-directed regimens in gastrointestinal malignancies: a retrospective cohort study","year":2026,"journal":"BMC Cancer","source_url":"https://doi.org/10.1186/s12885-026-16309-3","status":"verified"},{"title":"Efficacy and Safety of Once-Daily Oral Paltusotine in Patients with Carcinoid Syndrome: Results from a Phase 2 Multicentre Study","year":2026,"journal":"SSRN Electronic Journal","source_url":"https://doi.org/10.2139/ssrn.6261586","status":"verified"},{"title":"Ersodetug Series Supplementary Information","year":2026,"journal":"Zenodo (CERN European Organization for Nuclear Research)","source_url":"https://doi.org/10.5281/zenodo.20147071","status":"verified"}],"source":"works"},"contact":{"address_1":"300 PASTEUR DR","city":"Stanford","state":"CA","zip":"943052200","phone":"650-723-4000","source":"identity"},"similar":[{"name":"Jeffrey Teuteberg","slug":"jeffrey-teuteberg","institution":"Stanford Medicine","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/jeffrey-teuteberg","json_url":"https://www.findmykol.com/kol/jeffrey-teuteberg/profile.json"},{"name":"Charles Debattista","slug":"charles-debattista","institution":"Stanford Medicine","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/charles-debattista","json_url":"https://www.findmykol.com/kol/charles-debattista/profile.json"},{"name":"Jong Yoon","slug":"jong-yoon","institution":"Stanford Medicine","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/jong-yoon","json_url":"https://www.findmykol.com/kol/jong-yoon/profile.json"},{"name":"Kimberly Dequattro","slug":"kimberly-dequattro","institution":"Stanford Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/kimberly-dequattro","json_url":"https://www.findmykol.com/kol/kimberly-dequattro/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":6,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-04-16","provider_certified":"2024-04-16","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022}},"methodology_url":"https://www.findmykol.com/about#methodology"}